11 February 2016 - Deborah Wilkes
Archived
Generics giant Mylan is set to acquire Sweden's Meda in a cash and shares deal worth SEK83.6 billion (US$9.9 billion), including debt.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.